Intuitive Surgical, Inc. $ISRG Shares Acquired by WINTON GROUP Ltd

WINTON GROUP Ltd increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 279.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,729 shares of the medical equipment provider’s stock after acquiring an additional 7,168 shares during the quarter. WINTON GROUP Ltd’s holdings in Intuitive Surgical were worth $5,510,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of ISRG. Norges Bank acquired a new position in shares of Intuitive Surgical in the 4th quarter worth $2,856,987,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Intuitive Surgical by 1,043.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock worth $760,124,000 after acquiring an additional 1,224,734 shares during the last quarter. Assenagon Asset Management S.A. grew its holdings in shares of Intuitive Surgical by 106.6% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after buying an additional 791,516 shares in the last quarter. Amundi grew its holdings in shares of Intuitive Surgical by 29.7% during the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock valued at $1,451,362,000 after buying an additional 739,444 shares in the last quarter. Finally, Sands Capital Management LLC grew its holdings in shares of Intuitive Surgical by 77.0% during the third quarter. Sands Capital Management LLC now owns 1,341,109 shares of the medical equipment provider’s stock valued at $599,784,000 after buying an additional 583,539 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the transaction, the senior vice president owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. The trade was a 46.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Mark Brosius sold 645 shares of the business’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the transaction, the senior vice president directly owned 1,613 shares of the company’s stock, valued at $782,321.13. This represents a 28.57% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 7,448 shares of company stock worth $3,224,404 in the last ninety days. 0.60% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $422.06 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $396.68 and a fifty-two week high of $603.88. The business has a 50-day moving average of $447.24 and a two-hundred day moving average of $501.02. The stock has a market capitalization of $149.48 billion, a P/E ratio of 51.16, a P/E/G ratio of 3.37 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter in the previous year, the firm earned $1.81 earnings per share. The business’s quarterly revenue was up 23.0% compared to the same quarter last year. As a group, research analysts expect that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on ISRG shares. TD Cowen lowered their price target on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a report on Wednesday, March 11th. Barclays set a $651.00 price target on Intuitive Surgical and gave the company an “overweight” rating in a report on Thursday, April 23rd. Jefferies Financial Group lowered their price target on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a report on Wednesday, April 22nd. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a report on Tuesday, June 2nd. Nineteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $573.63.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.